2021 – the year of the vaccine
January 12, 2021
New Year’s Eve, 2020 marked a full-year since the first case of SARS-CoV-2 was reported to the World Health Organisation China Office. What unfolded next shocked the world to its core as our global economy was brought to its knees and human resilience was pushed to its limits. Within the first three months of 2020, over 100 countries worldwide had instituted restrictions in a bid to stop the spread of the virus, affecting the majority...
Launching FH Brussels’ Recovery and Resurgence COVID-19 Practice
June 3, 2020
https://www.youtube.com/watch?v=flLZfiYRZcw The impact of the COVID-19 crisis across Europe is unprecedented. Economies have come to a stand still, many businesses have seen a massive reduction in their operations, and the impact on lives and livelihood is profound. When it comes to public affairs, there is certainly no ‘business as usual’. As we start to exit this crisis, we will find ourselves returning to a new norm – both the political and policy landscape have changed...
The Impact of COVID-19 on Innovation for Pharma Companies
April 10, 2020
Read Emma Cracknell's full article on our FH global website COVID-19 has united the general public, healthcare providers, governments, and industry around the goal of beating the virus. The world slowly begins to recover. Yet, global leaders will have to answer key questions. Could this have been prevented, should a treatment have been found sooner, and were there better ways to limit the spread of disease? Research and innovation from the pharmaceutical industry will play...
#EUinTwo: The Commission’s plan to beat cancer
March 25, 2020
Every year, 3.5 million people in the EU are diagnosed with cancer. Directly affecting 40% of EU citizens, cancer impacts the economy, health systems, and European society. To tackle this issue, the European Commission launched a new mandate on World Cancer Day. Officially titled Europe’s Beating Cancer Plan, the plan aims to strengthen the European approach at four key stages: prevention, diagnosis, treatment and survivorship. However, concrete actions have yet to be determined. To help...
‘Hemicycle Views’: Interviewing Spanish MEP Soledad Cabezón Ruiz (S&D)
May 8, 2019
With the EU Parliamentary elections just two weeks away, we are coming to the end of our ‘Hemicycle Views’ series. Watch also: Our launch video and very first interview with MEP Sirpa Pietikäinen In the wave of national elections in Spain, our final interview is with MEP Soledad Cabezón Ruiz, a politician for the Spanish Socialist Workers' Party and member of the European S&D Group. Since joining the European Parliament in 2014, as Member of the Environment, Public Health...
What might the next EU Health agenda look like?
January 30, 2019
The European Commission plays a key role in complementing Member State national health policies and ensuring health protection across all EU policies. Our healthcare policy expert Emma Cracknell shares her thoughts on the topics that the next Commission might look to cover. The health of Europe’s citizens is evolving alongside two trends: an ageing population and an increase in largely preventable diseases. By 2025, 20% of EU citizens will be over the age of 65...
What does the future (Commission) hold for access to medicines?
September 28, 2018
Over the past few years, the health policy landscape in Brussels has been characterised by the member states’ intense request for greater access to medicines. The primary focus has been on how prices could be reduced to increase access. However, drug shortages have equally remained on the radar. In June 2016, the Dutch Council Conclusions on strengthening checks and balances on the pharmaceutical industry have stirred political developments that have led to the ongoing intellectual...
#FHYearOfChange: Which healthcare issues should be on your radar past 2019?
September 3, 2018
2019 represents the “Year of Change” for the European Union (a new European Parliament, a new political leadership for the European Commission, and the formal departure of the UK as a member of the EU). With the European elections coming up in 2019, Senior Vice President and Director of Public Affairs, Teresa Calvano, notes what issues you should have on your radar in the healthcare sector. For Calvano, the rise of e-health, the digital transformation...
Claudio Murri & Dr Lukas Pfister Join FH Brussels as Senior Tech & Healthcare Advisers
September 13, 2017
FleishmanHillard is delighted to announce that Mr Claudio Murri and Dr Lukas Pfister have joined the firm as senior advisers to our technology and healthcare practices. Given the accelerating EU agendas in both of these sectors, increasing clients demands and opportunities for growth, we are excited to build upon existing expertise with these high caliber professionals. These senior profiles will work alongside our existing team of senior advisors which include Chris Davies, formerly the coordinator...